May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report

Emanuela Anastasi, Maria Grazia Porpora, Irene Pecorella, Silvia Bernardo, Luigi Frati, Pierluigi Benedetti Panici, Lucia Manganaro

Research output: Contribution to journalArticle

Abstract

We present a case of a 58-year-old menopausal woman referred to our hospital for the presence of large pelvic masses diagnosed by clinical examination and pelvic ultrasound. MRI examination showed voluminous bilateral capsulated multilocular ovarian cysts slightly hyperintense on T1-weighted images with thick septa and small papillary projections. CT scan confirmed the MRI findings. Among the ovarian tumor markers analyzed (CA125, HE4, and CA72.4), only Ca125 was slightly increased (48 U/ml). These data were suggestive of mucinous ovarian tumor. The patient underwent total hysterectomy with bilateral salpingo-oophorectomy, appendectomy, and multiple peritoneal biopsies. Pathological examination revealed bilateral borderline mucinous ovarian tumor with superficial atypical implants. Nine months later, the patient complained of left coxofemoral pain and underwent a PET/TC total body that suggested pubic bone metastases. Ovarian tumor markers were analyzed, and a second PET/TC was performed. CA125 was 252 U/ml, HE4 62 pM/L, and CA72.4>100 U/Ml. PET/TC was suggestive of peritoneal carcinosis. The patient was readmitted to the hospital. Clinical examination revealed small vaginal nodules. All nodules were excised. Microscopic analysis of all specimens revealed metastatic mucinous adenocarcinoma of intestinal type. The case shows that even a slight CA125 increase in the presence of a borderline ovarian tumor should not be overlooked since it can be indicative of a progressive disease. This case also highlights its additional diagnostic value when serum CA125 analysis is used in conjunction with MRI and CT imaging for the prognosis of mucinous borderline ovarian tumors (mBOTs).

Original languageEnglish
Pages (from-to)6969-6971
Number of pages3
JournalTumor Biology
Volume35
Issue number7
DOIs
Publication statusPublished - 2014

    Fingerprint

Keywords

  • Biomarker
  • Borderline ovarian cancer
  • CA125

ASJC Scopus subject areas

  • Cancer Research

Cite this

Anastasi, E., Porpora, M. G., Pecorella, I., Bernardo, S., Frati, L., Benedetti Panici, P., & Manganaro, L. (2014). May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report. Tumor Biology, 35(7), 6969-6971. https://doi.org/10.1007/s13277-014-1898-9